DRIO vs. MDAI, LNSR, MODD, CODX, RVP, ICU, LUCD, NMTC, FEMY, and CTCX
Should you be buying DarioHealth stock or one of its competitors? The main competitors of DarioHealth include Spectral AI (MDAI), LENSAR (LNSR), Modular Medical (MODD), Co-Diagnostics (CODX), Retractable Technologies (RVP), SeaStar Medical (ICU), Lucid Diagnostics (LUCD), NeuroOne Medical Technologies (NMTC), Femasys (FEMY), and Carmell (CTCX). These companies are all part of the "surgical & medical instruments" industry.
DarioHealth (NASDAQ:DRIO) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, community ranking, analyst recommendations, earnings and media sentiment.
DarioHealth currently has a consensus target price of $5.37, indicating a potential upside of 260.18%. Spectral AI has a consensus target price of $4.00, indicating a potential upside of 117.39%. Given DarioHealth's higher possible upside, research analysts plainly believe DarioHealth is more favorable than Spectral AI.
33.4% of DarioHealth shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 10.1% of DarioHealth shares are held by company insiders. Comparatively, 56.7% of Spectral AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
DarioHealth has a beta of 1.66, meaning that its share price is 66% more volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.
In the previous week, Spectral AI had 5 more articles in the media than DarioHealth. MarketBeat recorded 7 mentions for Spectral AI and 2 mentions for DarioHealth. Spectral AI's average media sentiment score of 0.53 beat DarioHealth's score of 0.30 indicating that Spectral AI is being referred to more favorably in the news media.
Spectral AI has a net margin of 0.00% compared to DarioHealth's net margin of -165.96%. Spectral AI's return on equity of 0.00% beat DarioHealth's return on equity.
Spectral AI has lower revenue, but higher earnings than DarioHealth.
DarioHealth received 237 more outperform votes than Spectral AI when rated by MarketBeat users. However, 100.00% of users gave Spectral AI an outperform vote while only 67.04% of users gave DarioHealth an outperform vote.
Summary
Spectral AI beats DarioHealth on 8 of the 15 factors compared between the two stocks.
Get DarioHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DRIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
DarioHealth Competitors List
Related Companies and Tools
